Norman Huangyu Lin

Dr. Norman Huangyu Lin

National University Hospital, Singapore
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
HWHon Jen Wong
Hon Jen Wong
NLNorman Huangyu Lin
Norman Huangyu Lin
YTYao Hao Teo
Yao Hao Teo
BYBrian S. Y. Yeo
Brian S. Y. Yeo
KTKeith Zhi Xian Toh
Keith Zhi Xian Toh
Ching-Hui SiaChing-Hui Sia
Ching-Hui Sia

RCRyan CH Chee
Ryan CH Chee
NLNorman Huangyu Lin
Norman Huangyu Lin
JHJamie Sin Ying Ho
Jamie Sin Ying Ho
ALAloysius Sheng‑Ting Leow
Aloysius Sheng‑Ting Leow
TLTony Y. W. Li
Tony Y. W. Li
Ching-Hui SiaChing-Hui Sia
Ching-Hui Sia
(1) Background: Little is known about how left ventricular systolic dysfunction (LVSD) affects functional and clinical outcomes in acute ischemic stroke (AIS) patients undergoing thrombolysis; (2) Methods: A retrospective observational study conducted between 2006 and 2018 included 937 consecutive AIS patients undergoing thrombolysis. LVSD was defined as left ventricular ejection fraction (LVEF) < 50%. Univariate and multivariate binary logistic regression analysis was performed for demographic characteristics. Ordinal shift regression was used for functional modified Rankin Scale (mRS) outcome at 3 months. Survival analysis of mortality, heart failure (HF) admission, myocardial infarction (MI) and stroke/transient ischemic attack (TIA) was evaluated with a Cox-proportional hazards model; (3) Results: LVSD patients in comparison with LVEF ≥ 50% patients accounted for 190 and 747 patients, respectively. LVSD patients had more comorbidities including diabetes mellitus (100 (52.6%) vs. 280 (37.5%), p < 0.001), atrial fibrillation (69 (36.3%) vs. 212 (28.4%), p = 0.033), ischemic heart disease (130 (68.4%) vs. 145 (19.4%), p < 0.001) and HF (150 (78.9%) vs. 46 (6.2%), p < 0.001). LVSD was associated with worse functional mRS outcomes at 3 months (adjusted OR 1.41, 95% CI 1.03–1.92, p = 0.030). Survival analysis identified LVSD to significantly predict all-cause mortality (adjusted HR [aHR] 3.38, 95% CI 1.74–6.54, p < 0.001), subsequent HF admission (aHR 4.23, 95% CI 2.17–8.26, p < 0.001) and MI (aHR 2.49, 95% CI 1.44–4.32, p = 0.001). LVSD did not predict recurrent stroke/TIA (aHR 1.15, 95% CI 0.77–1.72, p = 0.496); (4) Conclusions: LVSD in AIS patients undergoing thrombolysis was associated with increased all-cause mortality, subsequent HF admission, subsequent MI and poorer functional outcomes, highlighting a need to optimize LVEF.

13 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMing Xuan Han
Ming Xuan Han
AYAmelia Natasha Wen Ting Yeo
Amelia Natasha Wen Ting Yeo
Marcus Eng Hock OngMarcus Eng Hock Ong
Marcus Eng Hock Ong
KSKaren Smith
Karen Smith
YLYu Liang Lim
Yu Liang Lim
Qin Xiang NgQin Xiang Ng
Qin Xiang Ng
Out-of-hospital cardiac arrests (OHCAs) occurring in high-rise buildings are a challenge to Emergency Medical Services (EMS). Contemporary EMS guidelines lack specific recommendations for systems and practitioners regarding the approach to these patients. This scoping review aimed to map the body of literature pertaining to OHCAs in high-rise settings in order to clarify concepts and understanding and to identify knowledge gaps. Databases were searched from inception through to 6 May 2021 including OVID Medline, PubMed, Embase, CINAHL, and Scopus. Twenty-three articles were reviewed, comprising 8 manikin trials, 14 observational studies, and 1 mathematical modelling study. High-rise settings commonly have lower availability of bystanders and automatic external defibrillators (AEDs), while height constraints often lead to delays in EMS interventions and suboptimal cardiopulmonary resuscitation (CPR), scene access, and extrication. Four studies found return of spontaneous circulation (ROSC) rates to be significantly poorer, while seven studies found rates of survival-to-hospital discharge (n = 3) and neurologically favourable survival (n = 4) to be significantly lower in multistorey settings. Mechanical chest compression devices, transfer sheets, and strategic defibrillator placement were suggested as approaches to high-rise OHCA management. A shift to maximising on-scene treatment time, along with bundling novel prehospital interventions, could ameliorate some of these difficulties and improve clinical outcomes for patients.

1 December 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
NCNicholas WS Chew
Nicholas WS Chew
KPKailun Phua
Kailun Phua
YHYeung Jek Ho
Yeung Jek Ho
AZAudrey Zhang
Audrey Zhang
NLNorman Huangyu Lin
Norman Huangyu Lin
KPKian-Keong Poh
Kian-Keong Poh

Verified
Journal Article
Open access
PDF file
HWHon Jen Wong
Hon Jen Wong
TKTze Siang Koh
Tze Siang Koh
ZBZong Rui Bai
Zong Rui Bai
SLShian Yi Jessele Lai
Shian Yi Jessele Lai
NGNicholas L. X. Gao
Nicholas L. X. Gao
Ching-Hui SiaChing-Hui Sia
Ching-Hui Sia
Objectives: Severe mitral regurgitation (MR) has been associated with significant morbidity and mortality, necessitating effective risk stratification. The H2FPEF score has demonstrated prognostic value in other cardiac disorders. This study evaluates the prognostic utility of a modified version of the H2FPEF score for severe MR with preserved ejection fraction. Methods and Results: Patients from a tertiary cardiovascular referral center with consecutive index echocardiographic diagnoses of severe MR were included. We excluded patients with secondary MR, reduced LVEF ( 25 kg/m2) as opposed to the original cutoff (BMI > 30 kg/m2). Patients were stratified based on the modified score into low (0–1), intermediate (2–5), and high (6–9) groups. The primary endpoint, a composite of all-cause mortality and first heart failure hospitalization (HFH), was analyzed using multivariate Cox regression. A total of 388 patients (low 57 [14.7%]; intermediate 218 [56.2%]; high 113 [29.1%] modified H2FPEF score) were included with a median follow-up duration of 4.53 years (interquartile range 2.61 to 6.60). Patients with a high modified H2FPEF score were older, more likely to have hyperlipidemia, diabetes, end-stage renal disease, higher NYHA class, and lower LVEF. Malay ethnicity, hyperlipidemia, diabetes, end-stage renal disease and a higher indexed left atrial diameter were independently associated with greater modified H2FPEF score. High and intermediate modified H2FPEF scores were associated with the primary endpoint (HR 9.17, 95% CI 2.15–39.1 and 6.71, 95% CI 1.62–27.9 respectively) versus low scores. However, a Fine–Gray regression showed no difference in subdistribution hazards of first HFH between high and intermediate scores. Conclusions: The modified H2FPEF score may facilitate risk stratification for all-cause mortality and first HFH in patients with severe primary MR and preserved ejection fraction.